Disease-specific B cell clones are shared between patients with Crohn’s disease

B cells have important functions in gut homeostasis, and dysregulated B cell populations are frequently observed in patients with inflammatory bowel diseases, including both ulcerative colitis (UC) and Crohn's disease (CD). How these B cell perturbations contribute to disease remains largely unknown. Here, we perform deep sequencing of the B cell receptor (BCR) repertoire in four cohorts of patients with CD, together with healthy controls and patients with UC. We identify BCR clones that are shared between patients with CD but not found in healthy individuals nor in patients with UC, indicating CD-associated B cell immune responses. Shared clones are present in the inflamed gut mucosa, draining intestinal lymph nodes and blood, suggesting the presence of common CD-associated antigens that drive B cell responses in CD patients.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-04-17
DOI
https://doi.org/10.1038/s41467-025-58977-y
Citations
8
Primary Topic
T-cell and B-cell Immunology
Type
article
Field-Weighted Citation Impact
6.38

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Disease-specific B cell clones are shared between patients with Crohn’s disease

Kenneth G. C. Smith, Sofie H. Tolmeijer, Prasanti Kotagiri, Eoin McKinney et al.
8 citations
Nature Communications
T-cell and B-cell Immunology
6.38
article

Disease-specific B cell clones are shared between patients with Crohn’s disease

Kenneth G. C. Smith, Sofie H. Tolmeijer, Prasanti Kotagiri, Eoin McKinney, William Rae, Rachael Bashford-Rogers, Nurulamin M Noor, Paul Lyons, Ji-Yeun Lee, Lukas Unger, David Bingham, Scott D. Boyd, John Gubatan, Giulia Manferrari, Stephan Rogalla, Diana Pombal, Raoul S. Sojwal, Laura Bergamaschi, Samuel J. S. Rubin, Anton Stift, James Christopher Lee
article en
8 citations

Abstract

B cells have important functions in gut homeostasis, and dysregulated B cell populations are frequently observed in patients with inflammatory bowel diseases, including both ulcerative colitis (UC) and Crohn's disease (CD). How these B cell perturbations contribute to disease remains largely unknown. Here, we perform deep sequencing of the B cell receptor (BCR) repertoire in four cohorts of patients with CD, together with healthy controls and patients with UC. We identify BCR clones that are shared between patients with CD but not found in healthy individuals nor in patients with UC, indicating CD-associated B cell immune responses. Shared clones are present in the inflamed gut mucosa, draining intestinal lymph nodes and blood, suggesting the presence of common CD-associated antigens that drive B cell responses in CD patients.

Nature CommunicationsVol. 16(1)
AstraZeneca (United Kingdom) (GB), University of Cambridge (GB), The Francis Crick Institute (GB), University of Oxford (GB), Cambridge School (PT), AstraZeneca (Singapore) (SG), MRC Epidemiology Unit (GB), AstraZeneca (Germany) (DE), University College London (GB), Monash University (AU), Medical University of Vienna (AT), Stanford University (US)
Yale University, Wellcome Trust, Francis Crick Institute, Cancer Research UK, National Institute for Health and Care Research, Austrian Science Fund, National Institutes of Health, Medical Research Council, National Health and Medical Research Council, National Institute of Diabetes and Digestive and Kidney Diseases, Medical Research Foundation
Good health and well-being
Openalex Percentile: Top 3%
T-cell and B-cell Immunology
6.38
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.